GPNMB, an endogenous transmembrane protein, has emerged as a critical positive contributor to human carcinogenesis and is present at high levels in various types of cancers, thereby targeting GPNMB as an attractive strategy against cancer [37, 38]. Here, GPNMB is linked to cancer.